Individualized therapy is provided according to the best available evidence, clinical judgment, and patient preference, in order to maximize benefit and minimize risk [19]
G., Roberts L., et al
Some patients experience mild jitteriness during dose escalation that resolves within days, while others report persistent low-grade worry or panic sensations
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB
See Example Case 3 In case 3, an individual with documented vitamin B12 deficiency the neurotransmitter findings were: Epinephrine 4.2 g/go cretonne (8-12) Norepinephrine 26.6 g/grocer (30-55) Dopamine 89.2 g/grocer (125-175) Serotonin 48.6 g/grocer (175-225) GABA 7.0 mol/grocer (2.0-4.0) Glutamate 45.3 mol/grocer (10-25) PEA 529.70 nmol/grocer (175-350) Histamine 82.7 g/grocer (10-22) Cretonne 35.0 mg/do Glutathione in RBC 38 mol/L (200-400) The results show that the individual is low in epinephrine, norepinephrine, dopamine and serotonin, all related to diminished methionine cycle function and decreased methylation
N Engl J Med 390(13):11761185
